PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,924,026 | -13.0% | 2,228,066 | 0.0% | 0.00% | – |
| Q1 2023 | $5,659,287 | +37.6% | 2,228,066 | +1.3% | 0.00% | – |
| Q4 2022 | $4,112,406 | -26.4% | 2,199,148 | +1.1% | 0.00% | – |
| Q3 2022 | $5,589,000 | +43.4% | 2,174,625 | +7.7% | 0.00% | – |
| Q2 2022 | $3,898,000 | -42.4% | 2,019,686 | -11.4% | 0.00% | – |
| Q1 2022 | $6,768,000 | -30.3% | 2,278,878 | +5.4% | 0.00% | – |
| Q4 2021 | $9,706,000 | -7.6% | 2,161,773 | -0.0% | 0.00% | – |
| Q3 2021 | $10,506,000 | -28.4% | 2,161,818 | +0.5% | 0.00% | – |
| Q2 2021 | $14,667,000 | -5.3% | 2,150,521 | -2.0% | 0.00% | – |
| Q1 2021 | $15,494,000 | +11.7% | 2,194,665 | -1.0% | 0.00% | – |
| Q4 2020 | $13,873,000 | +24.4% | 2,216,128 | +7.5% | 0.00% | – |
| Q3 2020 | $11,155,000 | +18.2% | 2,061,906 | +14.1% | 0.00% | – |
| Q2 2020 | $9,434,000 | +96.2% | 1,807,152 | +18.4% | 0.00% | – |
| Q1 2020 | $4,808,000 | -13.5% | 1,526,673 | +10.7% | 0.00% | – |
| Q4 2019 | $5,557,000 | -4.6% | 1,378,882 | +2.3% | 0.00% | – |
| Q3 2019 | $5,822,000 | -8.9% | 1,347,837 | -15.9% | 0.00% | – |
| Q2 2019 | $6,394,000 | +8.3% | 1,602,747 | +45.5% | 0.00% | – |
| Q1 2019 | $5,904,000 | +86.7% | 1,101,570 | +78.7% | 0.00% | – |
| Q4 2018 | $3,162,000 | -76.6% | 616,314 | -55.7% | 0.00% | -100.0% |
| Q3 2018 | $13,504,000 | -1.8% | 1,392,044 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $13,751,000 | -10.1% | 1,348,228 | +14.6% | 0.00% | 0.0% |
| Q1 2018 | $15,294,000 | -9.7% | 1,176,449 | +24.4% | 0.00% | 0.0% |
| Q4 2017 | $16,932,000 | -28.6% | 945,930 | +0.1% | 0.00% | 0.0% |
| Q3 2017 | $23,713,000 | +13.4% | 944,756 | +8.9% | 0.00% | 0.0% |
| Q2 2017 | $20,909,000 | +50.0% | 867,616 | +19.8% | 0.00% | 0.0% |
| Q1 2017 | $13,942,000 | +36.9% | 724,300 | +9.5% | 0.00% | 0.0% |
| Q4 2016 | $10,182,000 | +36.0% | 661,179 | +14.9% | 0.00% | – |
| Q3 2016 | $7,489,000 | +25.8% | 575,617 | +34.5% | 0.00% | – |
| Q2 2016 | $5,953,000 | +7.8% | 427,928 | +17.5% | 0.00% | – |
| Q1 2016 | $5,523,000 | -17.1% | 364,043 | +3.6% | 0.00% | – |
| Q4 2015 | $6,664,000 | +4.9% | 351,266 | +5.1% | 0.00% | – |
| Q3 2015 | $6,353,000 | -20.6% | 334,324 | +7.7% | 0.00% | -100.0% |
| Q2 2015 | $7,999,000 | +13.0% | 310,402 | +37.1% | 0.00% | – |
| Q1 2015 | $7,077,000 | -16.1% | 226,387 | +3.5% | 0.00% | -100.0% |
| Q4 2014 | $8,433,000 | – | 218,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|